In preclinical models of DCM, cardiac dysfunction has been linked to decreased expression of endothelial nitric oxide synthase 3 (NOS3) and increased levels of phosphodiesterase 5A (PDE5A) within myocardial tissues. This evidence concerns the gene NOS3 and familial dilated cardiomyopathy.